ISF-402 is an insulin sensitizer potentially for the treatment of type 2 diabetes. ISF-402 is a zinc binding peptide that disperses hexameric insulin in vitro, and potentiates the activity of hexameric insulin more so than monomeric lispro insulin. References: Paule SG, Nikolovski B, Ludeman J, Gray RE, Spiccia L, Zimmet PZ, Myers MA. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers. Peptides. 2009 Jun;30(6):1088-97. doi: 10.1016/j.peptides.2009.02.020. PubMed PMID: 19463741.

纯度：≥98%

CAS：484649-95-8